Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease

被引:6
|
作者
de Oliveira Rezende Jr, Celso [1 ]
Martinez, Pablo David Grigol [1 ]
Ferreira, Rafael Augusto Alves [1 ]
Koovits, Paul John [1 ]
Soares, Bruna Miranda [1 ]
Ferreira, Leonardo L. G. [2 ]
Michelan-Duarte, Simone [2 ]
Chelucci, Rafael Consolin [2 ]
Andricopulo, Adriano D. [2 ]
Matheeussen, An [3 ]
Van Pelt, Natascha [3 ]
Caljon, Guy [3 ]
Maes, Louis [3 ]
Campbell, Simon [4 ]
Kratz, Jadel M. [4 ]
Mowbray, Charles E. [4 ]
Dias, Luiz Carlos [1 ]
机构
[1] Univ Campinas UNICAMP, Inst Chem, BR-13083861 Campinas, SP, Brazil
[2] Univ Sao Paulo, Phys Inst Sao Carlos, Lab Med & Computat Chem, BR-13563120 Sa Carlos, SP, Brazil
[3] Lab Microbiol Parasitol & Hyg LMPH, Univ Pl 1, B-2610 Antwerp, Belgium
[4] Drugs Neglected Dis Initiat DNDi, 15 Chemin Camille Vidart, CH-1202 Geneva, Switzerland
基金
巴西圣保罗研究基金会;
关键词
2-Aminobenzimidazole derivatives; Chagas disease; Hit-to-lead; Multiparametric optimization; Trypanosoma cruzi; DRUG DISCOVERY; BENZNIDAZOLE;
D O I
10.1016/j.ejmech.2022.114925
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Chagas disease is a neglected tropical disease caused by Trypanosoma cruzi. Because current treatments present several limitations, including long duration, variable efficacy and serious side effects, there is an urgent need to explore new antitrypanosomal drugs. The present study describes the hit-to-lead optimization of a 2-aminoben-zimidazole hit 1 identified through in vitro phenotypic screening of a chemical library against intracellular Trypanosoma cruzi amastigotes, which focused on optimizing potency, selectivity, microsomal stability and lip-ophilicity. Multiparametric Structure-Activity Relationships were investigated using a set of 277 derivatives. Although the physicochemical and biological properties of the initial hits were improved, a combination of low kinetic solubility and in vitro cytotoxicity against mammalian cells prevented progression of the best compounds to an efficacy study using a mouse model of Chagas disease.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Hit-to-lead optimization of novel 2-alkylaminomethylquinoline derivatives as anti-chagas agents
    Muscia, Gisela C.
    Roldan Pacheco, Federico J.
    Asis, Silvia E.
    Buldain, Graciela Y.
    Frank, Fernanda M.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 186
  • [2] Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents
    Koovits, Paul J.
    Dessoy, Marco A.
    Matheeussen, An
    Maes, Louis
    Caljon, Guy
    Ferreira, Leonardo L. G.
    Chelucci, Rafael C.
    Michelan-Duarte, Simone
    Andricopulo, Adriano D.
    Campbell, Simon
    Kratz, Jadel M.
    Mowbray, Charles E.
    Dias, Luiz C.
    RSC MEDICINAL CHEMISTRY, 2020, 11 (11): : 1267 - 1274
  • [3] Synthetic Medicinal Chemistry in Chagas' Disease: Compounds at The Final Stage of "Hit-To-Lead" Phase
    Cerecetto, Hugo
    Gonzalez, Mercedes
    PHARMACEUTICALS, 2010, 3 (04): : 810 - 838
  • [4] Enhancing the hit-to-lead properties of lead optimization libraries
    Pickett, SD
    McLay, IM
    Clark, DE
    JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2000, 40 (02): : 263 - 272
  • [5] Hit-to-lead optimization of a pyrazinylpiperazine series against Leishmania infantum and Leishmania braziliensis
    Lapierre, Thibault Joseph William Jacques Dit
    Cruz, Mariza Gabriela Faleiro de Moura Lodi
    Brito, Nicolas Peterson Ferreira
    Resende, Daniela de Melo
    Souza, Felipe de Oliveira
    Pilau, Eduardo Jorge
    da Silva, Meryck Felipe Brito
    Neves, Bruno Junior
    Murta, Silvane Maria Fonseca
    Rezende Junior, Celso de Oliveira
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 256
  • [6] NEW, SIMPLE SYNTHESIS OF 2-AMINOBENZIMIDAZOLE
    WEISS, S
    MICHAUD, H
    PRIETZEL, H
    KROMMER, H
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1973, 12 (10): : 441 - 441
  • [7] IDENTIFICATION AND EARLY HIT-TO-LEAD OPTIMIZATION OF NOVEL DRUG CANDIDATES FOR THE TREATMENT OF HUMAN AFRICAN TRYPANOSOMIASIS
    Orr, Matthew D.
    Chen, Daitao
    Perales, Joe B.
    Bolduc, Kyle
    Freeman, Jennifer C.
    Nguyen, Tien
    Noe, Robert A.
    Rewerts, Cindy
    Shrestha, Mohanish
    Sligar, Jessica M.
    Nare, Bakela
    Wring, Stephen A.
    Jacobs, Robert
    Don, Robert
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 79 (06): : 158 - 158
  • [8] Substituted 2-arylbenzothiazoles as kinase inhibitors: Hit-to-lead optimization
    Tasler, Stefan
    Mueller, Oliver
    Wieber, Tanja
    Herz, Thomas
    Pegoraro, Stefano
    Saeb, Wael
    Lang, Martin
    Krauss, Rolf
    Totzke, Frank
    Zirrgiebel, Ute
    Ehlert, Jan E.
    Kubbutat, Michael H. G.
    Schaechtele, Christoph
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (18) : 6728 - 6737
  • [9] Novel Triazeneindole Antibiotics: Synthesis and Hit-to-Lead Optimization
    Sorokin, Boris
    Filimonova, Alla
    Emelianova, Anna
    Kublitski, Vadim
    Gvozd, Artem
    Shmygarev, Vladimir
    Yampolsky, Ilia
    Guglya, Elena
    Gusev, Evgeniy
    Kuzmin, Denis
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (05)
  • [10] Hit-to-lead optimization of a new class of compound to treat human African trypanosomiasis
    Ferrins, Lori
    Rahmani, Raphael
    Russell, Stephanie
    Jones, Amy
    Nghi Nguyen
    Newson, Harriet
    Sykes, Melissa
    Avery, Vicky
    Piggott, Matthew
    Baell, Jonathan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250